# Aldosterone in Diabetic Nephropathy

> **NCT00870402** · PHASE4 · UNKNOWN · sponsor: **Universidad de los Andes, Chile** · enrollment: 160 (estimated)

## Conditions studied

- Diabetic Nephropathy

## Interventions

- **DRUG:** Spironolactone
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00870402
- **Lead sponsor:** Universidad de los Andes, Chile
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2009-03
- **Primary completion:** 2009-12
- **Final completion:** 2010-03
- **Target enrollment:** 160 (ESTIMATED)
- **Last updated:** 2009-03-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00870402

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00870402, "Aldosterone in Diabetic Nephropathy". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT00870402. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*